This trial is !
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Eosinophilic Esophagitis
and you are
between 5 and 25
years old
2
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The purpose of this study is to test the safety and effectiveness of Losartan potassium in subjects with Eosinophilic Esophagitis (EoE), both those with a connective tissue disorder (CTD) and those without a CTD.

Provided treatments

  • Drug: Losartan Potassium
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03029091. The sponsor of the trial is Children's Hospital Medical Center, Cincinnati and it is looking for 15 volunteers for the current phase.
Official trial title:
A Preliminary Open-Label Trial of Losartan Potassium in Participants With Eosinophilic Esophagitis (EoE) With or Without a Connective Tissue Disorder